Background. The Drug Resistance in Pneumonia score (DRIP) is a recently developed prediction tool to identify patients with community-acquired pneumonia (CAP) at increased risk for drug resistant pathogens (DRP). The DRIP score has better performance characteristics than other available prediction tools which have been associated with increased broad-spectrum antibiotic use. We evaluated the potential impact of the DRIP score on CAP management at the Salt Lake City VA, a 106 bed facility with a Hospitalist service staffed by Internal Medicine residents and Department of Medicine faculty and an antibiotic stewardship program (ASP).
Impact of Antimicrobial Stewardship Program Guidance on the Management of Community-Acquired Pneumonia in Hospitalized Adults
Thomas Walsh, MD; Matthew Moffa, DO; Holly Bean, DO; Courtney Watson, MPH and Derek Bremmer, PharmD, BCPS; Allegheny Health Network, Pittsburgh, Pennsylvania Session: 168. Stewardship: Improving Outcomes Friday, October 6, 2017: 12:30 PM Background. Community-acquired pneumonia (CAP) is often treated with prolonged antibiotic therapy and unnecessary utilization of broad-spectrum antibiotics. An Antimicrobial Stewardship Program (ASP) bundled initiative, which included dissemination of a clinical decision algorithm, procalcitonin guidance, and prospective audit with feedback by the ASP team, was implemented.
Methods. A retrospective, pre-intervention/post-intervention study was conducted to compare management for patients admitted with CAP before and after implementation of the ASP-bundled initiative. The pre-intervention period was March 1, 2014 through October 31, 2014, and the intervention period was September 1, 2015 through April 30, 2016.
Results. A total of 39 and 61 patients were included in the pre-intervention and post-intervention cohorts, respectively. When compared with the pre-intervention group, mean duration of therapy decreased (9.0 vs. 5.6 days; P < 0.001). More patients received an appropriate duration of 7 days or less (38.5% vs. 80.3%; P < 0.001), while fewer received courses of more than 10 days (28.2% vs. 3.3%; P < 0.001). Fewer patients received intravenous vancomycin (28.2% vs. 4.9%; P = 0.002) and anti-pseudomonal β-lactams (25.6% vs. 6.6%; P = 0.02). Pneumonia-related 30-day re-admission rates (5.1% vs. 4.9%; P = 0.99) were unaffected. In the post-intervention group, patients with procalcitonin levels < 0.25µg/L received shorter duration of therapy compared with patients with levels > 0.25µg/L (4.5 vs. 6.9 days; P = 0.001).
Conclusion. A syndrome-specific approach to antimicrobial stewardship practices, incorporating procalcitonin-guidance, led to shorter durations of therapy and decreased use of broad-spectrum antibiotics for the treatment of CAP without affecting hospital re-admissions.
Disclosures. Methods. Cross-sectional analysis of antimicrobial prescribing at 30 U.S. children's hospitals. Participating hospitals were academic, tertiary care hospitals in the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) collaborative. Subjects were children 0-17 years with an active antibiotic order at 0800 on a single day during three consecutive calendar quarters (Q3 2016 -Q1 2017). Each hospital's ASP used a standardized survey to collect data on antibiotic orders and evaluate appropriateness. Data were pooled from the three surveys. The primary outcome was the pooled estimate for the percentage of prescriptions classified as inappropriate. Secondary outcomes were pooled estimates for indication, reason for inappropriate use, and ASP review status for each antibiotic.
Results. Of 19,598 children hospitalized on survey days, 6,922 (35%) had ≥1 active antibiotic order. Median age of children receiving antibiotics was 3.7 years (0.5, 10.9). Figures 1 and 2 show the most common antibiotics and indications. Of all antibiotic orders, 1,514 (15%) were classified as inappropriate, and 19% of patients with antibiotic orders had at least one inappropriate order. The most common reasons for inappropriate use were bug-drug mismatch (26%), surgical prophylaxis > 24 hours (18%) and unnecessary duplicate therapy (12%). ASPs would not have routinely reviewed 50% of all inappropriate orders. An additional 22% of inappropriate orders were for antibiotics typically reviewed by ASPs, but were yet to be reviewed at the time of the survey.
Conclusion. Across 30 children's hospitals, approximately 1 in 3 hospitalized children is receiving an antibiotic at any given time. Almost 20% of these children are receiving inappropriate therapy, and a substantial portion of inappropriate use is not captured by current ASP practices. 
